Experience mental healthcare with a new approach
ATMA provides psychedelic education and training to practitioners so you can offer this ground-breaking treatment to your mental health patients.
SUPPORTING YOUR PRACTICE AT EVERY STEP
Training for psychedelic-assisted therapy
Through the unique healing and transformative experiences of psychedelic-assisted therapy, we are witnessing a new frontier of treatment that is providing hope to those struggling with mental health concerns.
Creating a standard for which psychedelic therapists should be trained is an important step in the evolution of this field. ATMA’s psychedelic therapy courses help establish this standard of care. Healthcare professionals who achieve competency in this area will be able to adopt this treatment into their practice upon legalization of these medicines.
Your psychedelic training begins with us
Globally renowned leaders in the medical community have partnered with ATMA to develop the curricula, training models, and lectures for the psychedelic therapy course offerings.
Introduction to Psychedelic-assisted Therapy
This CE credited course offers an overview of psychedelic medicines in a convenient manner, allowing for healthcare professionals to gain familiarity with psychedelic therapy medicine.
Advanced Psychedelic-assisted Therapy (PaT) Certification Program
This program will provide the opportunity for legal experiential training under the supervision of skilled psychedelic guides and medical practitioners.
ATMA ACADEMY ALUMNI
Meet our ATMA Academy Alumni from around the world
We’re proud to support mental health practitioners from around the world with our programs and initiatives. Learn how our students enjoyed learning with ATMA Academy.
Meet your instructors
Our teaching faculty features a number of leading experts in their respective fields.
Leading psilocybin therapy clinical trials and research
Health Canada has approved our Phase I Study that aims to assess the safety of psilocybin in healthcare workers.
Our Phase II Study aims to assess the efficacy of psilocybin in treating frontline healthcare workers presenting with COVID-19-related depression, anxiety, or burnout has recently been submitted to Health Canada for approval.
Lastly, we plan to conduct future studies with palliative care patients experiencing end-of-life anxiety.
ATMA's goals to support psychedelic therapists in their training
Connect with your peers and industry leaders
With our community platform, we provide a solution for therapists looking to connect and network with one another. Our platform will continually support therapists, whether operating in a clinic or working independently. A supportive environment fosters higher levels of engagement; the sharing of data and experiences will lead to increased efficacy and will inform best practice
Stay up-to-date with the latest research
We are building the largest online community platform for psychedelic therapy practitioners by offering a clear, guided path for therapy providers to practicably adopt psychedelic-assisted therapy. Share data and experiences, facilitate group discussions, find support services and stay up-to-date with emerging research.
Access your course materials
Access your video lectures, training materials, and most recent research and updates on the current landscape of psychedelic medicines on our platform. Track your progress with our platform and interact with other students as well as your instructors.
Exclusive discounts and events
ATMA Academy Alumni will have access to these community-based platforms, allowing for them to be actively involved in the psychedelic community and to be part of the paradigm shift the world is experiencing. Gain access to exclusive discounts and events as alumni.